Monday, August 28, 2017

When can we hear about the conquest of liver cancer? 

When can we hear about the conquest of liver cancer? 

“Early detection of liver cancer in Korea is only one fourth of those in Japan,” says Park Joong-won, chairman of the Liver Cancer Association, who has hopes in immune checkpoint inhibitors

Liver cancer, one of the four deadliest cancers in Korea, is called a "silent killer" because the diagnosis and the treatment are tricky.

Incidence rate of Hepatitis B, which has been cited as one of the major causes of liver cancer, has been significantly reduced due to the improved vaccination and treatment. But how come the incidence of liver cancer and the follow-up reduction in deaths have fallen short of expectations?

I visited the National Cancer Center (NCC)국립암센터 to interview Park Joong-Won박중원, a nationally renowned liver cancer expert, for an explanation to the question above and the best possible liver cancer treatment. Professor Park has been serving as chairman of the Liver Cancer Association since July.

Continue reading....

No comments:

Post a Comment